Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3970ff2929243c84b2f197df598b9c59 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 |
filingDate |
2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81afa7d3a0033d4b1da67ed06a0a3ba3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38a31d1785e772b34b013de75b927cde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b80c29fc09389d8108669d689ec295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2976caa6080acd1bf91b66d1fe31505e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_704cab6a976d4d2ae77be45d1c783a00 |
publicationDate |
2022-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114028426-A |
titleOfInvention |
Application of As2O3 microbial leachate in the preparation of drugs for reducing the phosphorylation level of protein kinase B |
abstract |
The invention belongs to the field of biomedicine and relates to a new use of an As 2 O 3 microbial leaching solution, in particular to the application of an As 2 O 3 microbial leaching solution in preparing a medicine for reducing the phosphorylation level of protein kinase B. The As 2 O 3 microbial leaching solution provided by the invention can significantly reduce the phosphorylation level of protein kinase B in cells, and can be used for the treatment of diabetes and cancer. |
priorityDate |
2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |